A new study published in the journal of BMC Pulmonary Medicine showed that 10% of psoriasis patients would have interstitial ...
Zasocitinib is under clinical development by Takeda Pharmaceutical and currently in Phase I for Systemic Lupus Erythematosus.
Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.